The Desmond Tutu
HIV Foundation

Pairing rigorous research with community-driven development, the DTHF is making a substantial contribution to service delivery and public health policy relating to HIV, tuberculosis and related infections in South Africa.

About Us Our People

HIV weekly news update in partnership with MedicalBrief

  • MEDICALBRIEF Issue No 0181 – HIV News 23 November 2017

    Special journal issue on new approaches to managing HIV

    A PLOS Medicine Special Issue: Advances in HIV Prevention, Treatment and Cure highlights important research in the field.
  • MEDICALBRIEF Issue No 0181 – HIV News 23 November 2017

    No transmissions from breastfeeding in Tanzania cohort

    No HIV exposed infants who were negative at birth, whose mothers started antiretroviral therapy (ART) before delivery, had suppressed viral loads and exclusively breastfed, were HIV positive after breastfeeding, in a rural African cohort.
  • MEDICALBRIEF Issue No 0181 – HIV News 23 November 2017

    Viral loads’ study reveals new cohort at risk of therapy failure

    A large South African cohort study found that patients with low level viraemia (400-999 copies/mL) had an almost fivefold risk of treatment failure compared to patients with a VL<50 copies/ml.
  • MEDICALBRIEF Issue No 0181 – HIV News 23 November 2017

    Dual-HIV-regimen found to be a simple, safe salvage therapy

    The dual combination of dolutegravir (DTG) plus darunavir/ritonavir (DRV/r) provided a simple and safe salvage therapy to suppress viral replication without metabolic impact in patients infected with HIV-1.
  • MEDICALBRIEF Issue No 0181 – HIV News 23 November 2017

    Long-term data do not support raltegravir as second-line therapy

    A second-line HIV regimen containing the integrase inhibitor raltegravir failed to meet its primary endpoint of non-inferiority against standard second-line treatment with nucleoside reverse-transcriptase inhibitors, or NRTIs, according to 144-week data from the EARNEST trial.
View All

Our Research


Teens Trust the Tutu Teen Truck!

The Tutu Teen Truck is a non-traditional health clinic on the back of a truck. This free service is not …
Read More

Students at High Risk of HIV Infection Regard Themselves as ‘Safe’

In sub-Saharan Africa, adolescent girls and young women between the ages of 15-24 accounted for 25% of new HIV infections …
Read More

IAVI Fellowship Grant Applications in Adolescent HIV/TB Research 2018

The Desmond Tutu HIV Foundation (DTHF) at the University of Cape Town, in partnership with the International AIDS Vaccine Initiative …
Read More

Research Trials at Emavundleni

The Emavundleni research centre is a branch of the Desmond Tutu HIV Foundation that specialises in HIV prevention and also …
Read More

Our Projects

Desmond Tutu HIV Centre: Postgraduate Diploma in TB-HIV Medicine

Overview The Desmond Tutu HIV Centre and the University of Cape Town are proud to present the first online postgraduate …
Read More

The Tutu Tester

HIV and TB are managed successfully in many countries around the world. Yet, millions of people are still missing care. …
Read More

Adult HIV Educational Programme

Order a Manual Free Online Manual The aim of the HIV education programme is to improve the care of men …
Read More


Youth Centre
Youth Centre

The DTHF Youth Centre

The DTHF Youth Centre complex in Masiphumelele was built in response to requests from the community for a safe, recreational space for young people. DTHF surveys record a high prevalence of HIV infection among youth in the community.

Visit the Youth Centre